#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Retinopathy proliferative Conjunctivitis allergic Propionic acidaemia Liposarcoma Non-renal cell carcinoma of kidney Thrombocytosis Biliary neoplasm Chronic granulomatous disease Vascular calcification Crigler-Najjar syndrome Duchenne muscular dystrophy Anaplastic large cell lymphoma T- and null-cell types Leiomyosarcoma recurrent Medulloblastoma Mitochondrial DNA depletion More trials…

    Learn about Rare Diseases

    Haemophilia A with anti factor VIII – Basic Information Choroid melanoma – Treatment Lennox-Gastaut syndrome – Diagnostics Mantle cell lymphoma – Diagnostics Nephrotic syndrome – Life with Disease Loeys-Dietz syndrome – Treatment Haemophilia Osteosarcoma metastatic – Trials in Disease Netherton’s syndrome Retinitis pigmentosa – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Nitrofurantoin GSKVX000000048110 Ucp4 Catequentinib Dihydrochloride Roflumilast Imiglucerase Cholic Acid Bisacodyl Meglumine Gadoterate Sapablursen VERTEPORFIN Zalunfiban Lysine Hydrochloride Domperidone AGALSIDASE BETA TAGRAXOFUSP Caffeine Citrate Clofazimine Eptacog Beta (Activated) Topotecan More therapies…

    Learn about Your Condition

    Breast cancer stage I Malignant oligodendroglioma Ocular melanoma Skin ulcer Colon cancer Breast cancer female Ewing's sarcoma recurrent Synovial sarcoma recurrent BK virus infection Iron deficiency Hyperchylomicronaemia Prolymphocytic leukaemia Alcoholism Immunosuppression Transient ischaemic attack More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on Stopping or Continuing Clopidogrel, Carbasalate Calcium, and Dipyridamole for Young Patients After Stroke Without a Known Cause

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Cerebrovascular accident
    Investigated Drugs:
    • Carbasalate Calcium
    • Dipyridamole
    • Clopidogrel
    The Netherlands

  • Study on Cannabidiol and Dronabinol for Children with Refractory Epilepsy

    Recruiting

    3 1
    Investigated Diseases:
    • Epilepsy
    Investigated Drugs:
    • Cannabidiol
    • Dronabinol
    The Netherlands

  • Study on Preoperative Chemoradiotherapy with Capecitabine and Temozolomide for Patients with Locally Advanced Rectal Cancer

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Temozolomide
    • Capecitabine
    Italy

  • Study of Venetoclax, Ibrutinib, and Rituximab for Patients with Untreated Chronic Lymphocytic Leukemia

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Chronic lymphocytic leukaemia
    Investigated Drugs:
    • Venetoclax
    Italy

  • Study of Ibrutinib and Obinutuzumab for Patients with Chronic Lymphocytic Leukemia Who Have Not Received Treatment Before

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • B-cell small lymphocytic lymphoma
    • Chronic lymphocytic leukaemia
    Investigated Drugs:
    • Ibrutinib
    Italy

  • Study on Metformin for Patients with Esophageal Cancer to Enhance Chemoradiotherapy Response

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Oesophageal adenocarcinoma
    Investigated Drugs:
    • Metformin Hydrochloride
    The Netherlands
Previous Page
1 … 331 332 333 334 335 … 1,650
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!